Free Access
Volume 25, Juillet 2016
Médecine interne et transversalité
Page(s) S119 - S122
Section Éditorial / Editorial
Published online 02 June 2016
  • Vachon F (2010) Histoire de la réanimation médicale française : 1954–1975. Réanimation 20:72–8 [CrossRef] [Google Scholar]
  • Misset JL (2013) History of medical oncology. Bull Cancer 100:403–6 [PubMed] [Google Scholar]
  • Institut Natioanal du Cancer (2016) Projection de l’incidence et de la mortalité par cancer en France métropolitaine en 2015 - Rapport technique. [Google Scholar]
  • Sarfati D, Koczwara BJackson C (2016) The impact of comorbidity on cancer and its treatment. CA Cancer J Clin [in press] [Google Scholar]
  • Torre LA, Siegel RL, Ward EM, et al (2016) Global Cancer Incidence and Mortality Rates and Trends-An Update. Cancer Epidemiol Biomarkers Prev 25:16–27 [CrossRef] [PubMed] [Google Scholar]
  • DALYs GBD, Collaborators H, Murray CJ, et al (2015) Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet 386:2145–91 [CrossRef] [PubMed] [Google Scholar]
  • Fraser J, Steele N, Al Zaman A, et al (2011) Are patients in clinical trials representative of the general population? Dose intensity and toxicities associated with FE100C-D chemotherapy in a non-trial population of node positive breast cancer patients compared with PACS-01 trial group. Eur J Cancer 47:215–20 [CrossRef] [PubMed] [Google Scholar]
  • Azoulay E, Pene F, Darmon M, et al (2015) Managing critically ill hematology patients: Time to think differently. Blood Rev 29:359–67 [CrossRef] [PubMed] [Google Scholar]
  • Shrime MG, Ferket BS, Scott DJ, et al (2016) Time-Limited Trials of Intensive Care for Critically Ill Patients With Cancer: How Long Is Long Enough? JAMA Oncol 2:76–83 [CrossRef] [PubMed] [Google Scholar]
  • Hainsworth JD, Rubin MS, Spigel DR, et al (2013) Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site : a prospective trial of the Sarah Cannon research institute. J Clin Oncol 31:217–23 [CrossRef] [PubMed] [Google Scholar]
  • Greco FA, Lennington WJ, Spigel DR, et al (2013) Molecular profiling diagnosis in unknown primary cancer : accuracy and ability to complement standard pathology. J Natl Cancer Inst 105:782–90 [CrossRef] [PubMed] [Google Scholar]
  • Bos MM, de Keizer NF, Meynaar IA, et al (2012) Outcomes of cancer patients after unplanned admission to general intensive care units. Acta Oncol 51:897–905 [CrossRef] [PubMed] [Google Scholar]
  • Merceron S, Canet E, Lemiale V, et al (2014) Palliative vasoactive therapy in patients with septic shock. Chest 146:e107–8 [CrossRef] [PubMed] [Google Scholar]
  • Ades F, Zardavas D, Pinto AC, et al (2014) Cardiotoxicity of systemic agents used in breast cancer. Breast 23:317–28 [CrossRef] [PubMed] [Google Scholar]
  • Groeger JS, Lemeshow S, Price K, et al (1998) Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol 16:761–70 [PubMed] [Google Scholar]
  • Ho TH, Barbera L, Saskin R, et al (2011) Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol 29:1587–91 [CrossRef] [PubMed] [Google Scholar]
  • Loggers ET, Maciejewski PK, Paulk E, et al (2009) Racial differences in predictors of intensive end-of-life care in patients with advanced cancer. J Clin Oncol 27:5559–64 [CrossRef] [PubMed] [Google Scholar]
  • Mack JW, Cronin A, Keating NL, et al (2012) Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol 30:4387–95 [CrossRef] [PubMed] [Google Scholar]
  • Volandes AE, Paasche-Orlow MK, Mitchell SL, et al (2013) Randomized controlled trial of a video decision support tool for cardiopulmonary resuscitation decision making in advanced cancer. J Clin Oncol 31:380–6 [CrossRef] [PubMed] [Google Scholar]
  • Yun YH, Lee MK, Kim SY, et al (2011) Impact of awareness of terminal illness and use of palliative care or intensive care unit on the survival of terminally ill patients with cancer: prospective cohort study. J Clin Oncol 29:2474–80 [CrossRef] [PubMed] [Google Scholar]
  • Christodoulou C, Rizos M, Galani E, et al (2007) Performance status (PS): a simple predictor of short-term outcome of cancer patients with solid tumors admitted to the intensive care unit (ICU). Anticancer Res 27:2945–8 [PubMed] [Google Scholar]
  • Puxty K, McLoone P, Quasim T, et al (2014) Survival in solid cancer patients following intensive care unit admission. Intensive Care Med 40:1409–28 [CrossRef] [PubMed] [Google Scholar]
  • Fu S, Hong DS, Naing A, et al (2011) Outcome analyses after the first admission to an intensive care unit in patients with advanced cancer referred to a phase I clinical trials program. J Clin Oncol 29:3547–52 [CrossRef] [PubMed] [Google Scholar]
  • Earle CC, Neville BA, Landrum MB, et al (2004) Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22:315–21 [CrossRef] [PubMed] [Google Scholar]
  • Lesieur O, Leloup M, Gonzalez F, et al (2015) Withholding or withdrawal of treatment under French rules: a study performed in 43 intensive care units. Ann Intensive Care 5:56 [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.